Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study

BMC Health Services Research
D H LeeJ de Castro

Abstract

Data are scarce regarding real-world health care resource use (HCRU) for non-small cell lung cancer (NSCLC). An understanding of current clinical practices and HCRU is needed to provide a benchmark for rapidly evolving NSCLC management recommendations and therapeutic options. The objective of this study was to describe real-world HCRU for patients with advanced NSCLC. This multinational, retrospective chart review study was conducted at academic and community oncology sites in Italy, Spain, Germany, Australia, Japan, South Korea, Taiwan, and Brazil. Deidentified data were drawn from medical records of 1440 adults (≥18 years old) who initiated systemic therapy (2011 to mid-2013) for a new, confirmed diagnosis of advanced or metastatic (stage IIIB or IV) NSCLC. We summarized HCRU associated with first and subsequent lines of systemic therapy for advanced/metastatic NSCLC. The proportion of patients who were hospitalized at least once varied by country from 24% in Italy to 81% in Japan during first-line therapy and from 22% in Italy to 84% in Japan during second-line therapy; overall hospitalization frequency was 2.5-11.1 per 100 patient-weeks, depending on country. Emergency visit frequency also varied among countries (overall fr...Continue Reading

References

Sep 25, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Louis P GarrisonC Daniel Mullins
Aug 6, 2008·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Chun-Ru ChienMei-Shu Lai
Sep 23, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Marjolein PompenPieter Postmus
Sep 26, 2008·The New England Journal of Medicine·Roy S HerbstScott M Lippman
Nov 5, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Kathleen LangDavid Thompson
Dec 3, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Daniel MorgenszternRamaswamy Govindan
Feb 16, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Sri NavaratnamKetan Badiani
Apr 17, 2010·Current Medical Research and Opinion·Helge G BischoffNicholas Thatcher
Jul 6, 2010·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M W J M WoutersF M N H Schramel
May 14, 2011·Lancet·Peter GoldstrawFrances A Shepherd
Nov 15, 2011·BMC Health Services Research·Montserrat Vera-LlonchGerry Oster
Apr 14, 2012·Journal of Medical Imaging and Radiation Oncology·Sharlyn KangBin Jalaludin
Aug 27, 2013·Lancet·Martin ReckKlaus F Rabe
Oct 18, 2013·The Lancet Oncology·Ramon Luengo-FernandezRichard Sullivan
Dec 24, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lesley A HensonBarbara A Daveson
Dec 30, 2014·Cancer Research and Treatment : Official Journal of Korean Cancer Association·June-Koo LeeDae Seog Heo
Mar 10, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Denis Moro-SibilotPhilipp A Schnabel
May 13, 2015·Seminars in Oncology·Martin Reck, Luis Paz-Ares
Nov 22, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·N van der LindenC A Uyl-de Groot
Jun 3, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel Morgensztern, Roy S Herbst
Jul 2, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Ting-Yuan David ChengMary E Reid

❮ Previous
Next ❯

Citations

Dec 18, 2020·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Kyung-In JoungDong Churl Suh
Jan 9, 2022·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jordan D HildenbrandThomas W Leblanc

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

SAS
EPICLIN
Lung

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.